These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33442013)

  • 1. Treatment of one eye affects both.
    Stower H
    Nat Med; 2021 Jan; 27(1):21. PubMed ID: 33442013
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy.
    Vignal C; Uretsky S; Fitoussi S; Galy A; Blouin L; Girmens JF; Bidot S; Thomasson N; Bouquet C; Valero S; Meunier S; Combal JP; Gilly B; Katz B; Sahel JA
    Ophthalmology; 2018 Jun; 125(6):945-947. PubMed ID: 29426586
    [No Abstract]   [Full Text] [Related]  

  • 3. Leber Hereditary Optic Neuropathy: Bringing the Lab to the Clinic.
    Rasool N; Lessell S; Cestari DM
    Semin Ophthalmol; 2016; 31(1-2):107-16. PubMed ID: 26959136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poison and antidote: a novel model to study pathogenesis and therapy of LHON.
    Manfredi G; Beal MF
    Ann Neurol; 2004 Aug; 56(2):171-2. PubMed ID: 15293268
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene Therapy for Leber Hereditary Optic Neuropathy: Is Vision Truly RESCUED?
    Chen JJ; Bhatti MT
    Ophthalmology; 2021 May; 128(5):661-662. PubMed ID: 33892900
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene Therapy for Leber Hereditary Optic Neuropathy: Low- and Medium-Dose Visual Results.
    Guy J; Feuer WJ; Davis JL; Porciatti V; Gonzalez PJ; Koilkonda RD; Yuan H; Hauswirth WW; Lam BL
    Ophthalmology; 2017 Nov; 124(11):1621-1634. PubMed ID: 28647203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for Leber congenital amaurosis.
    Dejneka NS; Surace EM; Bennett J
    Adv Exp Med Biol; 2003; 533():415-22. PubMed ID: 15180293
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual Acuity Testing Before and After Intravitreal Injection of rAAV2-ND4 in Patients.
    Li B; Wu C
    Methods Mol Biol; 2018; 1715():305-311. PubMed ID: 29188523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are we there yet? Is neuro-ophthalmology at the cusp of a paradigm shift? Lessons from leber hereditary optic neuropathy.
    Sadun AA
    J Neuroophthalmol; 2013 Jun; 33(2):189-97. PubMed ID: 23681244
    [No Abstract]   [Full Text] [Related]  

  • 10. Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion.
    Carelli V; d'Adamo P; Valentino ML; La Morgia C; Ross-Cisneros FN; Caporali L; Maresca A; Loguercio Polosa P; Barboni P; De Negri A; Sadun F; Karanjia R; Salomao SR; Berezovsky A; Chicani F; Moraes M; Moraes Filho M; Belfort R; Sadun AA
    Brain; 2016 Mar; 139(Pt 3):e17. PubMed ID: 26657166
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.
    Feuer WJ; Schiffman JC; Davis JL; Porciatti V; Gonzalez P; Koilkonda RD; Yuan H; Lalwani A; Lam BL; Guy J
    Ophthalmology; 2016 Mar; 123(3):558-70. PubMed ID: 26606867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply: Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion.
    Yu-Wai-Man P; Hudson G; Klopstock T; Chinnery PF
    Brain; 2016 Mar; 139(Pt 3):e18. PubMed ID: 26657167
    [No Abstract]   [Full Text] [Related]  

  • 13. [To the last frontier].
    Yamamoto S
    Nippon Ganka Gakkai Zasshi; 2008 Aug; 112(8):667-8. PubMed ID: 18767490
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene Therapies for the Treatment of Leber Hereditary Optic Neuropathy.
    Sahel JA; Newman NJ; Yu-Wai-Man P; Vignal-Clermont C; Carelli V; Biousse V; Moster ML; Sergott R; Klopstock T; Sadun AA; Blouin L; Katz B; Taiel M
    Int Ophthalmol Clin; 2021 Oct; 61(4):195-208. PubMed ID: 34584057
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy for mitochondrial diseases: Leber Hereditary Optic Neuropathy as the first candidate for a clinical trial.
    Cwerman-Thibault H; Augustin S; Ellouze S; Sahel JA; Corral-Debrinski M
    C R Biol; 2014 Mar; 337(3):193-206. PubMed ID: 24702846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Cases of Leber's Hereditary Optic Neuropathy with Rapid Increase in Visual Acuity After Gene Therapy.
    Zhang Y; Yuan JJ; Liu HL; Tian Z; Liu SW; Li B
    Curr Gene Ther; 2019; 19(2):134-138. PubMed ID: 31237206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical research progress of gene therapy for Leber hereditary optic neuropathy].
    Wu YJ; Li WS
    Zhonghua Yan Ke Za Zhi; 2018 Aug; 54(8):636-640. PubMed ID: 30107658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good news on the clinical gene transfer front.
    Wilson JM; Gansbacher B; Berns KI; Bosch F; Kay MA; Naldini L; Wei YQ
    Hum Gene Ther; 2008 May; 19(5):429-30. PubMed ID: 18507511
    [No Abstract]   [Full Text] [Related]  

  • 19. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
    Chun BY; Rizzo JF
    Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral vectors containing a retinal pigment epithelium specific promoter for leber congenital amaurosis gene therapy. Lentiviral gene therapy for LCA.
    Bemelmans AP; Kostic C; Hornfeld D; Jaquet M; Crippa SV; Hauswirth WW; Lem J; Wang Z; Schorderet DE; Munier FL; Wenzel A; Arsenijevic Y
    Adv Exp Med Biol; 2006; 572():247-53. PubMed ID: 17249581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.